Structure and function of a thymic peptide is mimicked by Plasmodium falciparum peptides.
Dubois. P P; Dardenne. M M; Fandeur. T T; Mercereau-Puijalon. O O; Mattei. D D; Müller-Hill. B B; Blisnick. T T; Pereira da Silva. L L
Key Findings
- Malaria antigens Pf11‑1 and Pf332 share sequence similarity with thymosin‑alpha‑1
- Antibodies raised against Pf11‑1 cross‑react with synthetic thymosin‑alpha‑1
- Synthetic malaria peptides can mimic some biological activities of thymosin‑alpha‑1
Practical Outcomes
- For biohackers, this study mainly adds a mechanistic insight: thymosin‑alpha‑1’s immune effects are recognizable to malaria proteins, but it doesn’t change how you would dose or use the peptide. It reinforces the idea that thymosin‑alpha‑1 can modulate immunity, yet offers no new actionable protocol.
Summary
Researchers found that some malaria proteins look a lot like the human immune‑boosting peptide thymosin‑alpha‑1, and the antibodies they made against the malaria pieces also stick to thymosin‑alpha‑1. The malaria pieces even act a bit like thymosin‑alpha‑1 in lab tests, suggesting the parasite may copy our immune signals to hide from us.
Abstract
Numerous Plasmodium falciparum antigens contain repetitive amino acid sequences. Two blood stage antigens, Pf11-1 and Pf332, were characterized in our laboratories and present high cross-reactivities, defining a family of cross-reacting antigens. In this report, we show that amino acid sequence homologies might explain these cross-reactivities, but that they extend to polypeptides from the host, namely thymosin-alpha 1 (T alpha 1). An antiserum raised in chickens and Saimiri monkeys against the synthetic Pf11-1 peptide cross-reacts with synthetic T alpha 1. Synthetic Pf11-1 and Pf332 peptides share some of the biological activities of T alpha 1. These results are discussed with respect to the mechanisms devised by malaria parasites for escape from the host immune response.
Study Information
pubmed
1988
1988-09-01T00:00:00.000Z
10.1016/0769-2625(88)90100-6
10
15